Correlation Between Merit Medical and MusclePharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merit Medical and MusclePharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merit Medical and MusclePharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merit Medical Systems and MusclePharm, you can compare the effects of market volatilities on Merit Medical and MusclePharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merit Medical with a short position of MusclePharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merit Medical and MusclePharm.

Diversification Opportunities for Merit Medical and MusclePharm

-0.26
  Correlation Coefficient

Very good diversification

The 3 months correlation between Merit and MusclePharm is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Merit Medical Systems and MusclePharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MusclePharm and Merit Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merit Medical Systems are associated (or correlated) with MusclePharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MusclePharm has no effect on the direction of Merit Medical i.e., Merit Medical and MusclePharm go up and down completely randomly.

Pair Corralation between Merit Medical and MusclePharm

Given the investment horizon of 90 days Merit Medical is expected to generate 64.03 times less return on investment than MusclePharm. But when comparing it to its historical volatility, Merit Medical Systems is 45.0 times less risky than MusclePharm. It trades about 0.05 of its potential returns per unit of risk. MusclePharm is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  0.30  in MusclePharm on September 4, 2024 and sell it today you would lose (0.30) from holding MusclePharm or give up 100.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy84.99%
ValuesDaily Returns

Merit Medical Systems  vs.  MusclePharm

 Performance 
       Timeline  
Merit Medical Systems 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Merit Medical Systems are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Merit Medical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MusclePharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MusclePharm has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MusclePharm is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Merit Medical and MusclePharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merit Medical and MusclePharm

The main advantage of trading using opposite Merit Medical and MusclePharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merit Medical position performs unexpectedly, MusclePharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MusclePharm will offset losses from the drop in MusclePharm's long position.
The idea behind Merit Medical Systems and MusclePharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume